121 related articles for article (PubMed ID: 316767)
1. Circulating immune complexes in the serum of diabetes mellitus in childhood by a modified 125I-C1q binding test.
Nagaoka K; Chinen Y; Takegami T; Nabeya N; Sakurami T; Imura H; Kuno S; Tasaka K; Hamajima Y
Endocrinol Jpn; 1979 Oct; 26(5):527-32. PubMed ID: 316767
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
4. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
5. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
6. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
7. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
8. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
Narumoto J
Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
[TBL] [Abstract][Full Text] [Related]
9. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
Zubler RH; Lange G; Lambert PH; Miescher PA
J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
Wines BD; Easterbrook-Smith SB
Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
[TBL] [Abstract][Full Text] [Related]
12. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
Larsson A; Jonsson L; Sjöquist J
J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer.
Krieger G; Kneba M; Bolz I; Nagel GA
Clin Immunol Immunopathol; 1988 Jan; 46(1):14-23. PubMed ID: 3257175
[TBL] [Abstract][Full Text] [Related]
14. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
Hack CE; Belmer AJ
Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
[TBL] [Abstract][Full Text] [Related]
15. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
16. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
17. Increased C1q binding immune complexes in Felty's syndrome: comparison with uncomplicated rheumatoid arthritis.
Hurd ER; Chubick A; Jasin HE; Ziff M
Arthritis Rheum; 1979 Jul; 22(7):697-702. PubMed ID: 454498
[TBL] [Abstract][Full Text] [Related]
18. Influence of ionic strength, EDTA concentration, endogenous C1q and polyanions on the 125I-C1q-binding test.
Hack CE; Huijbregts CC; Paardekooper J
J Immunol Methods; 1984 Aug; 72(1):197-206. PubMed ID: 6205096
[TBL] [Abstract][Full Text] [Related]
19. Relevance of circulating immune complexes in childhood acute lymphoblastic leukaemia.
Clague RB; Kumar S; Hann IM; Jones PH; Holt PJ
Int J Cancer; 1978 Sep; 22(3):227-30. PubMed ID: 279522
[TBL] [Abstract][Full Text] [Related]
20. Clq binding activity in lupus erythematosus: correlation with the "lupus band test".
Tappeiner G; O'Loughlin S; Jordon RE
J Invest Dermatol; 1978 Apr; 70(4):187-90. PubMed ID: 305943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]